| 101 |
14727985 | Management of protease inhibitor-associated hyperlipidemia. | 2002 |
1 |
| 102 |
11197581 | Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin. | 2001 Jan |
2 |
| 103 |
11281188 | Myositis, microvesicular hepatitis, and progression to cirrhosis from troglitazone added to simvastatin. | 2001 Feb |
1 |
| 104 |
11465417 | Inhibition of in vitro metabolism of simvastatin by itraconazole in humans and prediction of in vivo drug-drug interactions. | 2001 May |
1 |
| 105 |
11475198 | [Metabolic interactions with statins]. | 2001 Jan 20 |
1 |
| 106 |
11497338 | Study of the drug-drug interaction between simvastatin and cisapride in man. | 2001 Jun |
1 |
| 107 |
11550401 | Simvastatin-diltiazem drug interaction resulting in rhabdomyolysis and hepatitis. | 2001 Sep |
2 |
| 108 |
11584328 | Treatment of the elderly with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors: focus on drug interactions. | 2001 Jul |
1 |
| 109 |
11753267 | Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin. | 2001 Dec |
4 |
| 110 |
10741630 | The interaction of diltiazem with simvastatin. | 2000 Mar |
5 |
| 111 |
11005703 | Comparative tolerability of the HMG-CoA reductase inhibitors. | 2000 Sep |
1 |
| 112 |
11029845 | HMG-CoA reductase inhibitors: assessing differences in drug interactions and safety profiles. | 2000 Sep-Oct |
1 |
| 113 |
11075313 | Simvastatin does not affect CYP3A activity, quantified by the erythromycin breath test and oral midazolam pharmacokinetics, in healthy male subjects. | 2000 Nov |
1 |
| 114 |
11126989 | [Undesirable drug interactions of hypolipemic drugs]. | 2000 Sep |
1 |
| 115 |
11149552 | Rhabdomyolysis and acute renal failure in a cardiac transplant recipient due to multiple drug interactions. | 2000 Dec |
1 |
| 116 |
11180018 | Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations. | 2000 Dec |
4 |
| 117 |
33237691 | Lipid and Lipoprotein Levels in Patients with COVID-19 Infections | 2000 |
1 |
| 118 |
10215754 | Metabolic interactions between mibefradil and HMG-CoA reductase inhibitors: an in vitro investigation with human liver preparations. | 1999 Mar |
1 |
| 119 |
10513779 | Concomitant use of cytochrome P450 3A4 inhibitors and simvastatin. | 1999 Oct 1 |
3 |
| 120 |
10665838 | New insights into the pharmacodynamic and pharmacokinetic properties of statins. | 1999 Dec |
1 |
| 121 |
9542477 | Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole. | 1998 Mar |
1 |
| 122 |
9728898 | Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations. | 1998 Aug |
1 |
| 123 |
9321523 | In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s. | 1997 Oct |
1 |